- Diabetic foot ulcers
- Venous leg ulcers
- Bed sores
- 1st & 2nd degree burns
- Donor site skin grafts
New Generation biotherapeutics with applied Recombinant Technology
REGEN-D ® 60
- REGEN-D® 60 (Recombinant Human Epidermal Growth Factor) is indicated for 1st & 2nd degree burns & donor site skin grafts
- Reduces wound healing time by 50%
- Quick & scarless healing
REGEN-D ® 150
- REGEN-D 150® (Recombinant Human Epidermal Growth Factor) is a new generation therapy for diabetic foot ulcers, bed sores & venous leg ulcers
- Reduces wound healing time by 50%
- Prevents limb amputation
SLVRGEN ®
- SLVRGEN® is a novel synergistic formulation for treatment of 1st & 2nd degree burns
- SLVRGEN® negates silver toxicity, prevents infection & shows faster healing activity
